India faces drug resistant leishmaniasisBMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7336.505/a (Published 02 March 2002) Cite this as: BMJ 2002;324:505
- Ganapati Mudur
- New Delhi
Untreated patients and drug resistant strains of the Leishmania donovani parasite are obstructing India's efforts to control leishmaniasis, doctors cautioned at a conference in New Delhi last week.
India's health ministry has announced a control plan that is aimed at reducing the incidence of leishmaniasis to 25% by the year 2005 and declaring India free of the infection by 2012.
“Less than 10% of the infected seek medical treatment, and 60% of cases in Bihar, the worst affected state, are resistant to the first line drug,” said Dr Philippe Desjeux, coordinator of leishmaniasis control at the World Health Organization in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial